MoneyWorks4Me

Panacea Biotec - Quaterly Results

14 Aug 2025 Evaluate
The topline advanced to Rs. 1122.50 millions, up 97.35% for the June 2025 quarter as against Rs. 568.80 millions during the year-ago period.The Net Loss for the quarter ended June 2025 is Rs. -67.00 millions as compared to Net Loss of Rs. -137.80 millions of corresponding quarter ended June 2024 Operating profit Margin for the quarter ended June 2025 improved to 19.30% as compared to -66.90% of corresponding quarter ended June 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 1122.50 568.80 97.35 1122.50 568.80 97.35 3098.50 3596.00 -13.83
Other Income 49.50 38.00 30.26 49.50 38.00 30.26 166.20 249.10 -33.28
PBIDT 19.30 -66.90 -128.85 19.30 -66.90 -128.85 96.90 390.80 -75.20
Interest 60.00 32.10 86.92 60.00 32.10 86.92 154.60 137.80 12.19
PBDT -40.70 -99.00 -58.89 -40.70 -99.00 -58.89 -57.70 253.00 -122.81
Depreciation 47.70 50.80 -6.10 47.70 50.80 -6.10 202.90 210.90 -3.79
PBT -88.40 -149.80 -40.99 -88.40 -149.80 -40.99 -260.60 42.10 -719.00
TAX -21.40 -12.00 78.33 -21.40 -12.00 78.33 -108.30 6.60 -1740.91
Deferred Tax -21.40 -12.00 78.33 -21.40 -12.00 78.33 -108.30 0.20 -54250.00
PAT -67.00 -137.80 -51.38 -67.00 -137.80 -51.38 -152.30 35.50 -529.01
Equity 61.30 61.30 0.00 61.30 61.30 0.00 61.30 61.30 0.00
PBIDTM(%) 1.72 -11.76 -114.62 1.72 -11.76 -114.62 3.13 10.87 -71.22
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..